Tyra Biosciences (TYRA) Other Gross PP&E Adjustments (2020 - 2026)
Quarterly Other Gross PP&E Adjustments fell 110.71% to -$284000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$990000.0 through Mar 2026, down 137.34% year-over-year, with the annual reading at -$316000.0 for FY2025, 88.87% up from the prior year.
Tyra Biosciences filings provide 7 years of Other Gross PP&E Adjustments readings, the most recent being -$284000.0 for Q1 2026.
- Other Gross PP&E Adjustments hit -$284000.0 in Q1 2026 for Tyra Biosciences, up from -$316000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $2.8 million in Q2 2024 and bottomed at -$2.8 million in Q4 2024.
- Average Other Gross PP&E Adjustments over 5 years is $897647.1, with a median of $1.3 million recorded in 2022.
- The largest annual shift saw Other Gross PP&E Adjustments surged 188.47% in 2022 before it crashed 551.15% in 2024.
- Tyra Biosciences' Other Gross PP&E Adjustments stood at $522000.0 in 2022, then crashed by 183.52% to -$436000.0 in 2023, then crashed by 551.15% to -$2.8 million in 2024, then soared by 88.87% to -$316000.0 in 2025, then rose by 10.13% to -$284000.0 in 2026.
- Per Business Quant, the three most recent readings for TYRA's Other Gross PP&E Adjustments are -$284000.0 (Q1 2026), -$316000.0 (Q4 2025), and -$181000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | -284,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -284,000.00 |
| Mar 31, 2026 | -284,000.00 |
| Dec 31, 2025 | -316,000.00 |
| Dec 31, 2025 | -316,000.00 |
| Sep 30, 2025 | -181,000.00 |
| Sep 30, 2025 | -181,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Mar 31, 2025 | 2.65 Mn |
| Mar 31, 2025 | 2.65 Mn |
| Dec 31, 2024 | -2.84 Mn |
| Dec 31, 2024 | -2.84 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 2.83 Mn |
| Jun 30, 2024 | 2.83 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Dec 31, 2023 | -436,000.00 |
| Dec 31, 2023 | -436,000.00 |
| Sep 30, 2023 | 1.60 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.49 Mn |
| Mar 31, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.51 Mn |
| Dec 31, 2022 | 522,000.00 |
| Dec 31, 2022 | 522,000.00 |
| Sep 30, 2022 | 1.40 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 1.34 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 957,000.00 |
| Dec 31, 2021 | 957,000.00 |
| Sep 30, 2021 | -1.59 Mn |
| Sep 30, 2021 | -1.59 Mn |
| Dec 31, 2020 | 125,000.00 |
| Dec 31, 2020 | 125,000.00 |